Alumis announces OLE data from phase 2 STRIDE clinical trial of ESK-001 to treat psoriasis: South San Francisco, California Tuesday, October 1, 2024, 13:00 Hrs [IST] Alumis Inc, a ...
Sun Pharma receives exclusive worldwide rights to commercialise Philogen’s Fibromun: Our Bureau, Mumbai Tuesday, October 1, 2024, 12:30 Hrs [IST] Sun Pharmaceutical Industries L ...
Some results have been hidden because they may be inaccessible to you